BioLife Solutions Inc
NASDAQ:BLFS
P/OCF
Price to OCF
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
Market Cap | P/OCF | ||||
---|---|---|---|---|---|
US |
BioLife Solutions Inc
NASDAQ:BLFS
|
801.5m USD | -64.1 | ||
JP |
Hoya Corp
TSE:7741
|
6.3T JPY | 30.9 | ||
CH |
Alcon AG
SIX:ALC
|
36B CHF | 28.5 | ||
DK |
Coloplast A/S
CSE:COLO B
|
190B DKK | 34.4 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
21B USD | 26.9 | ||
US |
Cooper Companies Inc
NYSE:COO
|
18.9B USD | 33.5 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
13.7T KRW | -122.9 | |
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
60.4B CNY | 42.6 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.4B GBP | 18.2 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.8B USD | 13.8 | ||
CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.3B USD | 66.4 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.